東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁 到查詢結果 [ null ]

切換: 標籤 | MARC模式 | ISBD

FindBook

Google Book

Amazon

博客來

Interactive associations of race and comorbidity in medication treatment and outcomes of Medicaid enrolled patients with major depressive disorder.

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Interactive associations of race and comorbidity in medication treatment and outcomes of Medicaid enrolled patients with major depressive disorder./
作者:	Wu, Chung-Hsuen.
出版者:	Ann Arbor : ProQuest Dissertations & Theses, : 2010,
面頁冊數:	184 p.
附註:	Source: Dissertations Abstracts International, Volume: 72-09, Section: B.
Contained By:	Dissertations Abstracts International72-09B.
標題:	Mental health. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3429310
ISBN:	9781124278971

Interactive associations of race and comorbidity in medication treatment and outcomes of Medicaid enrolled patients with major depressive disorder.
Wu, Chung-Hsuen.

Interactive associations of race and comorbidity in medication treatment and outcomes of Medicaid enrolled patients with major depressive disorder. - Ann Arbor : ProQuest Dissertations & Theses, 2010 - 184 p.

Source: Dissertations Abstracts International, Volume: 72-09, Section: B.

Thesis (Ph.D.)--University of Michigan, 2010.

This item must not be sold to any third party vendors.

Background. Comorbid anxiety disorders commonly occur in patients with Major Depressive Disorder (MDD). Treatment disparities of depression between African Americans and Caucasians still exist. Few studies have investigated the association of race and comorbid anxiety disorders with medication use-related outcomes in Medicaid enrollees with MDD. Objectives. The objectives of this study was to examine the association of race, comorbid anxiety disorders, and the interaction between race and comorbid anxiety disorders with medication adherence, medication persistence, and health resource utilization in Medicaid enrollees with MDD. Methods. MarketScan® Multi-State Medicaid Database were used in this retrospective cohort study. Adult Medicaid enrollees between 18 and 64 years of age with MDD but without bipolar disorders who received an antidepressant between January 1, 2004 and December 31, 2006 were identified. Patients with a 24-month continuous enrollment and without dual eligibility of Medicaid and Medicare were included. A Cox-propositional hazard regression was used to examine the risk of non-persistent antidepressant use. Multivariate logistic regressions were used to model the probability of adherence and health care utilization. Multivariate negative binominal regression analyses were used to assess the rate of change of health care utilization. Multivariate linear regressions with log-transformed costs were used to assess the health care costs. Results. Approximately 25% of 3,083 patients had comorbid anxiety disorders. After controlling for covariates, comorbid anxiety disorders were significantly associated with higher adherence and more frequent mental health-related health care utilization. African Americans were less likely than Caucasians to adhere to antidepressants and had higher risk of non-persistence. Additionally, African-American patients had fewer mental health-related office visits but were more likely to be hospitalized and have ER visits. The interaction effect (being African American and having comorbid anxiety disorders) reduced the individual association with health care utilization. Conclusion. African-American patients were less likely than Caucasian patients to be adherent to or persistently use antidepressants. Comorbid anxiety disorders were associated with higher health resource utilization. Health policy makers and health care providers need to decrease the disease burden of comorbid anxiety disorders and reduce health disparities between Caucasians and African Americans among Medicaid enrollees with MDD.

ISBN: 9781124278971Subjects--Topical Terms:

534751
Mental health.
Subjects--Index Terms:

Antidepressant

Interactive associations of race and comorbidity in medication treatment and outcomes of Medicaid enrolled patients with major depressive disorder.
LDR:03931nmm a2200409 4500 001 2344734
005 20220531065744.5
008 241004s2010 ||||||||||||||||| ||eng d
020 $a 9781124278971
035 $a (MiAaPQ)AAI3429310
035 $a AAI3429310
040 $a MiAaPQ $c MiAaPQ
100 1 $a Wu, Chung-Hsuen. $3 3683538
245 1 0 $a Interactive associations of race and comorbidity in medication treatment and outcomes of Medicaid enrolled patients with major depressive disorder.
260 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2010
300 $a 184 p.
500 $a Source: Dissertations Abstracts International, Volume: 72-09, Section: B.
500 $a Publisher info.: Dissertation/Thesis.
500 $a Advisor: Balkrishnan, Rajesh.
502 $a Thesis (Ph.D.)--University of Michigan, 2010.
506 $a This item must not be sold to any third party vendors.
520 $a Background. Comorbid anxiety disorders commonly occur in patients with Major Depressive Disorder (MDD). Treatment disparities of depression between African Americans and Caucasians still exist. Few studies have investigated the association of race and comorbid anxiety disorders with medication use-related outcomes in Medicaid enrollees with MDD. Objectives. The objectives of this study was to examine the association of race, comorbid anxiety disorders, and the interaction between race and comorbid anxiety disorders with medication adherence, medication persistence, and health resource utilization in Medicaid enrollees with MDD. Methods. MarketScan® Multi-State Medicaid Database were used in this retrospective cohort study. Adult Medicaid enrollees between 18 and 64 years of age with MDD but without bipolar disorders who received an antidepressant between January 1, 2004 and December 31, 2006 were identified. Patients with a 24-month continuous enrollment and without dual eligibility of Medicaid and Medicare were included. A Cox-propositional hazard regression was used to examine the risk of non-persistent antidepressant use. Multivariate logistic regressions were used to model the probability of adherence and health care utilization. Multivariate negative binominal regression analyses were used to assess the rate of change of health care utilization. Multivariate linear regressions with log-transformed costs were used to assess the health care costs. Results. Approximately 25% of 3,083 patients had comorbid anxiety disorders. After controlling for covariates, comorbid anxiety disorders were significantly associated with higher adherence and more frequent mental health-related health care utilization. African Americans were less likely than Caucasians to adhere to antidepressants and had higher risk of non-persistence. Additionally, African-American patients had fewer mental health-related office visits but were more likely to be hospitalized and have ER visits. The interaction effect (being African American and having comorbid anxiety disorders) reduced the individual association with health care utilization. Conclusion. African-American patients were less likely than Caucasian patients to be adherent to or persistently use antidepressants. Comorbid anxiety disorders were associated with higher health resource utilization. Health policy makers and health care providers need to decrease the disease burden of comorbid anxiety disorders and reduce health disparities between Caucasians and African Americans among Medicaid enrollees with MDD.
590 $a School code: 0127.
650 4 $a Mental health. $3 534751
650 4 $a Health sciences. $3 3168359
650 4 $a Public health. $3 534748
653 $a Antidepressant
653 $a Anxiety
653 $a Comorbidity
653 $a Depressive disorder
653 $a Medicaid patients
653 $a Medication treatment
653 $a Race
690 $a 0347
690 $a 0566
690 $a 0573
710 2 $a University of Michigan. $3 777416
773 0 $t Dissertations Abstracts International $g 72-09B.
790 $a 0127
791 $a Ph.D.
792 $a 2010
793 $a English
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3429310